NovaBiotics at American Society for Microbiology

Category: Events

Next week, the NovaBiotics’ team will be participating at the annual American Society for Microbiology conference (ASM, 1st – 5th June) in New Orleans. ASM showcases the best microbial science in the world, and provides a one of a kind forum to explore the complete spectrum of microbiology from basic science to translation and application.

Details of NovaBiotics’ oral presentations and posters on novel, AMR-mitigating antibacterial and antifungal agents are as follows:

Friday 2nd June 12.45pm – 2.45pm - Luminaderm an Antimicrobial Polymer for Nasal Decolonisation of Staphylococcus aureus

Saturday 3rd June 10.05am – 10.25am - A novel antifungal peptide candidate for invasive & mucocutaneous fungal infections

Saturday 3rd June 12.15pm – 2.15pm - Antifungal activity of NP339 in vivo in respiratory models of fungal infection

Saturday 3rd June 12.15pm – 2.15pm - NP339 as a novel approach against respiratory fungal infections

Saturday 3rd June 12.15pm – 2.15pm - Antifungal activity of NP339: A novel antifungal peptide

Sunday 4th June 12.15pm – 2.15pm - Cysteamine has a broad spectrum antimicrobial utility against emerging pathogens of cystic fibrosis associated with lung disease

Sunday 4th June 12.15pm – 2.15pm - NP432 (Novarifyn), a novel antimicrobial peptide rapidly active against multi-drug-resistant Acinetobacter baumannii and methicillin resistant Staphylococcus aureus